Ozenoxacin Cream, 1% - Topical Treatment of Impetigo

Skinmed. 2017 Feb 1;15(1):57-59. eCollection 2017.

Authors

Aditya K Gupta^{1

2}, Sarah G Versteeg², William Abramovits^{3

4

5}

Affiliations

¹ Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada, Dallas, TX; agupta@execulink.com.
² Mediprobe Research Inc., London, Ontario, Canada, Dallas, TX.
³ Department of Medicine, Baylor University Medical Center, Dallas, TX.
⁴ Departments of Dermatology and Family Practice, University of Texas Southwestern Medical School, Dallas, TX.
⁵ Dermatology Treatment and Research Center, Dallas, TX.

PMID: 28270312

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Administration, Topical
Adult
Aminopyridines / therapeutic use*
Anti-Bacterial Agents / therapeutic use
Female
Follow-Up Studies
Humans
Impetigo / diagnosis*
Impetigo / drug therapy*
Male
Ointments / administration & dosage
Quinolones / therapeutic use*
Severity of Illness Index
Treatment Outcome

Substances

Aminopyridines
Anti-Bacterial Agents
Ointments
Quinolones
ozenoxacin